246 related articles for article (PubMed ID: 31819410)
1. Anti-Angiogenic Activity Of Bevacizumab-Bearing Dexamethasone-Loaded PLGA Nanoparticles For Potential Intravitreal Applications.
Liu J; Zhang X; Li G; Xu F; Li S; Teng L; Li Y; Sun F
Int J Nanomedicine; 2019; 14():8819-8834. PubMed ID: 31819410
[TBL] [Abstract][Full Text] [Related]
2. Highly bioactive, bevacizumab-loaded, sustained-release PLGA/PCADK microspheres for intravitreal therapy in ocular diseases.
Liu J; Li S; Li G; Li X; Yu C; Fu Z; Li X; Teng L; Li Y; Sun F
Int J Pharm; 2019 May; 563():228-236. PubMed ID: 30959236
[TBL] [Abstract][Full Text] [Related]
3. Cyclic RGD Peptide Targeting Coated Nano Drug Co-Delivery System for Therapeutic Use in Age-Related Macular Degeneration Disease.
Liu J; Luo L; Xu F; Li G; Chen J; Teng L; Li Y; Sun F
Molecules; 2020 Oct; 25(21):. PubMed ID: 33113897
[TBL] [Abstract][Full Text] [Related]
4. Effect of nanoencapsulation using poly (lactide-co-glycolide) (PLGA) on anti-angiogenic activity of bevacizumab for ocular angiogenesis therapy.
Zhang XP; Sun JG; Yao J; Shan K; Liu BH; Yao MD; Ge HM; Jiang Q; Zhao C; Yan B
Biomed Pharmacother; 2018 Nov; 107():1056-1063. PubMed ID: 30257317
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic activity of PLGA-Lupeol implants for potential intravitreal applications.
Soares DCF; de Paula Oliveira DC; Barcelos LS; Barbosa AS; Vieira LC; Townsend DM; Rubello D; de Barros ALB; Duarte LP; Silva-Cunha A
Biomed Pharmacother; 2017 Aug; 92():394-402. PubMed ID: 28558353
[TBL] [Abstract][Full Text] [Related]
6. Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells.
Liu CT; Bi KW; Huang CC; Wu HT; Ho HY; S Pang JH; Huang ST
J Ethnopharmacol; 2017 Jan; 196():213-224. PubMed ID: 27993633
[TBL] [Abstract][Full Text] [Related]
7. Chitosan-Polycaprolactone Core-Shell Microparticles for Sustained Delivery of Bevacizumab.
Jiang P; Jacobs KM; Ohr MP; Swindle-Reilly KE
Mol Pharm; 2020 Jul; 17(7):2570-2584. PubMed ID: 32484677
[TBL] [Abstract][Full Text] [Related]
8. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
Qiu F; Meng T; Chen Q; Zhou K; Shao Y; Matlock G; Ma X; Wu W; Du Y; Wang X; Deng G; Ma JX; Xu Q
Mol Pharm; 2019 May; 16(5):1958-1970. PubMed ID: 30912953
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus loaded chitosan functionalized poly (lactic-co-glycolic acid) (PLGA) nanoparticles for potential treatment of age-related macular degeneration.
Suri R; Neupane YR; Mehra N; Nematullah M; Khan F; Alam O; Iqubal A; Jain GK; Kohli K
Int J Biol Macromol; 2021 Nov; 191():548-559. PubMed ID: 34536476
[TBL] [Abstract][Full Text] [Related]
10. Ultrastrong trapping of VEGF by graphene oxide: Anti-angiogenesis application.
Lai PX; Chen CW; Wei SC; Lin TY; Jian HJ; Lai IP; Mao JY; Hsu PH; Lin HJ; Tzou WS; Chen SY; Harroun SG; Lai JY; Huang CC
Biomaterials; 2016 Dec; 109():12-22. PubMed ID: 27639528
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory efficacy of intravitreal dexamethasone acetate-loaded PLGA nanoparticles on choroidal neovascularization in a laser-induced rat model.
Xu J; Wang Y; Li Y; Yang X; Zhang P; Hou H; Shi Y; Song C
J Ocul Pharmacol Ther; 2007 Dec; 23(6):527-40. PubMed ID: 18001232
[TBL] [Abstract][Full Text] [Related]
12. Anticancer and anti-angiogenic activities of extract from Actinidia eriantha Benth root.
Wu JG; Ma L; Lin SH; Wu YB; Yi J; Yang BJ; Wu JZ; Wong KH
J Ethnopharmacol; 2017 May; 203():1-10. PubMed ID: 28323051
[TBL] [Abstract][Full Text] [Related]
13. Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor.
Jin H; Pi J; Yang F; Wu C; Cheng X; Bai H; Huang D; Jiang J; Cai J; Chen ZW
Appl Microbiol Biotechnol; 2016 Aug; 100(15):6643-6652. PubMed ID: 26883344
[TBL] [Abstract][Full Text] [Related]
14. Anti-vascular Endothelial Growth Factor Antibody Limits the Vascular Leakage and Decreases Subretinal Fibrosis in a Cynomolgus Monkey Choroidal Neovascularization Model.
Inagaki S; Shimazawa M; Hamaguchi K; Otsu W; Araki T; Sasaki Y; Numata Y; Tsusaki H; Hara H
Curr Neurovasc Res; 2020; 17(4):420-428. PubMed ID: 32445455
[TBL] [Abstract][Full Text] [Related]
15. Axitinib-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles for Age-Related Macular Degeneration: Formulation Development and
Narvekar P; Bhatt P; Fnu G; Sutariya V
Assay Drug Dev Technol; 2019; 17(4):167-177. PubMed ID: 31184962
[No Abstract] [Full Text] [Related]
16. Thermo-responsive hydrogel as an anti-VEGF drug delivery system to inhibit retinal angiogenesis in Rex rabbits.
Hu CC; Chiu YC; Chaw JR; Chen CF; Liu HW
Technol Health Care; 2019; 27(S1):153-163. PubMed ID: 31045535
[TBL] [Abstract][Full Text] [Related]
17. Alkaloid extract of Corydalis yanhusuo inhibits angiogenesis via targeting vascular endothelial growth factor receptor signaling.
Wan L; Zhao Y; Zhang Q; Gao G; Zhang S; Gao Y; Chen X; Qian X
BMC Complement Altern Med; 2019 Dec; 19(1):359. PubMed ID: 31823762
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab-Conjugated Quantum Dots:
Santana CP; Mansur AAP; Mansur HS; Silva-Cunha AD
J Ocul Pharmacol Ther; 2020; 36(6):467-483. PubMed ID: 32522096
[No Abstract] [Full Text] [Related]
19. Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization due to Sorsby macular dystrophy.
Kapoor KG; Bakri SJ
J Ocul Pharmacol Ther; 2013 May; 29(4):444-7. PubMed ID: 23581613
[TBL] [Abstract][Full Text] [Related]
20. Comparison of long-acting bevacizumab formulations in the treatment of choroidal neovascularization in a rat model.
Pan CK; Durairaj C; Kompella UB; Agwu O; Oliver SC; Quiroz-Mercado H; Mandava N; Olson JL
J Ocul Pharmacol Ther; 2011 Jun; 27(3):219-24. PubMed ID: 21574814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
